|
US7763609B2
(en)
|
2003-12-15 |
2010-07-27 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
CA2628074C
(en)
|
2005-10-25 |
2014-01-14 |
Shionogi & Co., Ltd. |
Aminodihydrothiazine derivative
|
|
US8653067B2
(en)
|
2007-04-24 |
2014-02-18 |
Shionogi & Co., Ltd. |
Pharmaceutical composition for treating Alzheimer's disease
|
|
JP5383484B2
(ja)
*
|
2007-04-24 |
2014-01-08 |
塩野義製薬株式会社 |
環式基で置換されたアミノジヒドロチアジン誘導体
|
|
PL2233474T3
(pl)
|
2008-01-18 |
2015-12-31 |
Eisai R&D Man Co Ltd |
Skondensowana pochodna aminodihydrotiazyny
|
|
KR101324426B1
(ko)
|
2008-06-13 |
2013-10-31 |
시오노기세야쿠 가부시키가이샤 |
β 세크레타제 저해 작용을 갖는 황 함유 복소환 유도체
|
|
CN102105475B
(zh)
*
|
2008-07-28 |
2014-04-09 |
卫材R&D管理有限公司 |
螺氨基二氢噻嗪衍生物
|
|
JP5666304B2
(ja)
*
|
2008-09-30 |
2015-02-12 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
新規な縮合アミノジヒドロチアジン誘導体
|
|
CN102186841A
(zh)
|
2008-10-22 |
2011-09-14 |
盐野义制药株式会社 |
具有bace1抑制活性的2-氨基嘧啶-4-酮及2-氨基吡啶衍生物
|
|
GB0912777D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydropyrimidone derivatives
|
|
GB0912778D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydro-oxazine derivatives
|
|
WO2011044187A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
EP2485590B1
(en)
|
2009-10-08 |
2015-01-07 |
Merck Sharp & Dohme Corp. |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
EP2485920B1
(en)
|
2009-10-08 |
2016-04-27 |
Merck Sharp & Dohme Corp. |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
UA108363C2
(uk)
|
2009-10-08 |
2015-04-27 |
|
Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
|
|
MX2012006491A
(es)
|
2009-12-11 |
2012-07-03 |
Shionogi & Co |
Derivados de oxazina.
|
|
JPWO2011071109A1
(ja)
*
|
2009-12-11 |
2013-04-22 |
塩野義製薬株式会社 |
アミノ基を有する縮合ヘテロ環化合物
|
|
MX339640B
(es)
|
2010-06-09 |
2016-06-01 |
Janssen Pharmaceutica Nv * |
Derivados de 5, 6-dihidro-2h-[1, 4] oxazin-3-il-amina utiles como inhibidores de la beta-secretasa (bace).
|
|
JP5816630B2
(ja)
|
2010-10-29 |
2015-11-18 |
塩野義製薬株式会社 |
ナフチリジン誘導体
|
|
EP2634188A4
(en)
|
2010-10-29 |
2014-05-07 |
Shionogi & Co |
FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE
|
|
EP2655376B1
(en)
|
2010-12-22 |
2017-08-23 |
Janssen Pharmaceutica NV |
5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
|
|
GB201100181D0
(en)
*
|
2011-01-06 |
2011-02-23 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
ES2624288T3
(es)
*
|
2011-01-21 |
2017-07-13 |
Eisai R&D Management Co., Ltd. |
Métodos y compuestos útiles en la síntesis de derivados de aminodihidrotiazina condensados
|
|
GB201101140D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
GB201101139D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
AU2012224632B2
(en)
|
2011-03-09 |
2016-06-16 |
Janssen Pharmaceutica Nv |
3,4-dihydro-pyrrolo[1,2-a]pyrazin-1-ylamine derivatives useful as inhibitors of beta-secretase (BACE)
|
|
EP2694489B1
(en)
|
2011-04-07 |
2017-09-06 |
Merck Sharp & Dohme Corp. |
C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
EP2694521B1
(en)
|
2011-04-07 |
2015-11-25 |
Merck Sharp & Dohme Corp. |
Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
US8883779B2
(en)
|
2011-04-26 |
2014-11-11 |
Shinogi & Co., Ltd. |
Oxazine derivatives and a pharmaceutical composition for inhibiting BACE1 containing them
|
|
AR086539A1
(es)
|
2011-05-24 |
2014-01-08 |
Bristol Myers Squibb Co |
COMPUESTOS PARA LA REDUCCION DE LA PRODUCCION DE b-AMILOIDE
|
|
US8604024B2
(en)
|
2011-05-24 |
2013-12-10 |
Bristol-Myers Squibb Company |
Compounds for the reduction of beta-amyloid production
|
|
US8927535B2
(en)
*
|
2011-07-06 |
2015-01-06 |
Hoffman-La Roche Inc. |
Cyclopropyl-fused-1,3-thiazepines as BACE1 and/or BACE2 inhibitors
|
|
CN103874496A
(zh)
|
2011-08-22 |
2014-06-18 |
默沙东公司 |
作为bace抑制剂的2-螺-取代的亚氨基噻嗪类及其单和二氧化物、组合物及其用途
|
|
JP6043355B2
(ja)
|
2011-08-31 |
2016-12-14 |
ファイザー・インク |
ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
|
|
JO3143B1
(ar)
|
2012-04-03 |
2017-09-20 |
Lilly Co Eli |
مركبات تتراهيدرو بيرولو ثيازين
|
|
RU2014142545A
(ru)
|
2012-04-27 |
2016-06-27 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Способ получения 5-(дифторметил)пиразин-2-карбоновой кислоты и промежуточного соединения при ее получении
|
|
WO2013164730A1
(en)
|
2012-05-04 |
2013-11-07 |
Pfizer Inc. |
Heterocyclic substituted hexahydropyrano [3,4-d] [1,3] thiazin- 2 -amine compounds as inhibitors of app, bace1 and bace 2.
|
|
GB201212871D0
(en)
|
2012-07-20 |
2012-09-05 |
Eisai Ltd |
Novel compounds
|
|
EP2897964A1
(en)
|
2012-09-20 |
2015-07-29 |
Pfizer Inc. |
Alkyl-substituted hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds
|
|
EP2912035A4
(en)
|
2012-10-24 |
2016-06-15 |
Shionogi & Co |
DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY
|
|
SI2912041T1
(sl)
*
|
2012-10-26 |
2017-02-28 |
Eli Lilly And Company |
Derivati tetrahidropirolotiazina kot inhibitorji beta sekretaze (bace)
|
|
EP2931731A1
(en)
|
2012-12-11 |
2015-10-21 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
|
|
US9403846B2
(en)
|
2012-12-19 |
2016-08-02 |
Pfizer Inc. |
Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
US9475784B2
(en)
|
2012-12-19 |
2016-10-25 |
Bristol-Myers Squibb Company |
4,6-diarylaminothiazines as BACE1 inhibitors and their use for the reduction of beta-amyloid production
|
|
US9309263B2
(en)
|
2013-01-29 |
2016-04-12 |
Amgen Inc. |
Fused multi-cyclic sulfone compounds as inhibitors of beta-secretase and methods of use thereof
|
|
CA2899938C
(en)
|
2013-02-12 |
2021-10-19 |
Buck Institute For Research On Aging |
Hydantoins that modulate bace-mediated app processing
|
|
EP2956458B1
(en)
|
2013-02-13 |
2017-08-09 |
Pfizer Inc |
Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
US9233981B1
(en)
|
2013-02-15 |
2016-01-12 |
Pfizer Inc. |
Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
WO2014134341A1
(en)
*
|
2013-03-01 |
2014-09-04 |
Amgen Inc. |
Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
MX374512B
(es)
|
2013-03-08 |
2025-03-06 |
Amgen Inc |
Compuestos de 1,3-oxazin-2-amina fusionados con ciclopropilo perfluorado como inhibidores de beta-secretasa y métodos de uso.
|
|
TWI593692B
(zh)
|
2013-03-12 |
2017-08-01 |
美國禮來大藥廠 |
四氫吡咯并噻嗪化合物
|
|
MX368326B
(es)
|
2013-06-12 |
2019-09-27 |
Janssen Pharmaceutica Nv |
Derivados de 4-amino-6-fenil-5,6-dihidroimidazo[1,5-a]pirazin-3(2h )-ona como inhibidores de beta-secretasa (bace).
|
|
BR112015030597A2
(pt)
|
2013-06-12 |
2017-07-25 |
Janssen Pharmaceutica Nv |
derivados 4-amino-6-fenil-6,7-di-hidro[1,2,3]triazolo[1,5-a]pirazina como inibidores de beta-secretase (bace)
|
|
JO3318B1
(ar)
*
|
2013-06-18 |
2019-03-13 |
Lilly Co Eli |
مثبطات bace
|
|
WO2015017407A1
(en)
|
2013-07-30 |
2015-02-05 |
Amgen Inc. |
Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta- secretase
|
|
CN106459088A
(zh)
|
2014-04-10 |
2017-02-22 |
辉瑞公司 |
2‑氨基‑6‑甲基‑4，4a，5，6‑四氢吡喃并[3，4‑d][1，3]噻嗪‑8a(8H)‑基‑1，3‑噻唑‑4‑基酰胺
|
|
CN106795147B
(zh)
|
2014-08-08 |
2020-09-22 |
美国安进公司 |
作为β-分泌酶抑制剂的环丙基稠合噻嗪-2-胺化合物和使用方法
|
|
JO3458B1
(ar)
|
2014-11-10 |
2020-07-05 |
H Lundbeck As |
2- أمينو-6- (دايفلوروميثيل) – 5، 5- ديفلورو-6-فينيل-3،4، 5، 6-تيتراهيدروبيريدين كمثبطات bace1
|
|
MA40941A
(fr)
|
2014-11-10 |
2017-09-19 |
H Lundbeck As |
2-amino-5,5-difluoro-6-(fluorométhyl)-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1
|
|
CR20170187A
(es)
|
2014-11-10 |
2018-02-01 |
H Lundbeck As |
2-Amino-3,5-difluoro-6-metil-6-fenil-3,4,5,6-tetrahidropiridinas en calidad de inhibidores de BACE1 para el tratamiento de la enfermedad de Alzheimer
|
|
ES2768823T3
(es)
|
2014-12-18 |
2020-06-23 |
Janssen Pharmaceutica Nv |
Derivados de 2,3,4,5-tetrahidropiridin-6-amina y 3,4-dihidro-2H-pirrol-5-amina útiles como inhibidores de beta-secretasa
|
|
AR103680A1
(es)
|
2015-02-23 |
2017-05-24 |
Lilly Co Eli |
Inhibidores selectivos de bace1
|
|
WO2016149057A1
(en)
*
|
2015-03-19 |
2016-09-22 |
Eli Lilly And Company |
Selective bace1 inhibitors
|
|
AR104241A1
(es)
|
2015-04-29 |
2017-07-05 |
Lilly Co Eli |
Derivados de tetrahidrofuro tiazina como inhibidores de bace1 selectivos
|
|
WO2017024180A1
(en)
|
2015-08-06 |
2017-02-09 |
Amgen Inc. |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
TW201717948A
(zh)
|
2015-08-10 |
2017-06-01 |
Ｈ 朗德貝克公司 |
包括給予２－胺基－３，５，５－三氟－３，４，５，６－四氫吡啶的聯合治療
|
|
EP3334720A1
(en)
|
2015-08-12 |
2018-06-20 |
H. Lundbeck A/S |
2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyridins as bace1 inhibitors
|
|
EP3334738A1
(en)
*
|
2015-08-12 |
2018-06-20 |
H. Lundbeck A/S |
2-amino-7a-phenyl-3,4,4a,5,7,7a-hexahydrofuro[3,4-b]pyridines as bace1 inhibitors
|
|
WO2017051303A1
(en)
|
2015-09-24 |
2017-03-30 |
Pfizer Inc. |
Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
|
|
JP2018531923A
(ja)
|
2015-09-24 |
2018-11-01 |
ファイザー・インク |
Ｎ−［２−（２−アミノ−６，６−二置換−４，４ａ，５，６−テトラヒドロピラノ［３，４−ｄ］［１，３］チアジン−８ａ（８Ｈ）−イル）−１，３−チアゾール−４−イル］アミド
|
|
JP2018534251A
(ja)
|
2015-09-24 |
2018-11-22 |
ファイザー・インク |
Ｂａｃｅ阻害剤として有用なｎ−［２−（３−アミノ−２，５−ジメチル−１，１−ジオキシド−５，６−ジヒドロ−２ｈ−１，２，４−チアジアジン−５−イル）−１，３−チアゾール−４−イル］アミド
|
|
JOP20170106A1
(ar)
*
|
2016-05-20 |
2017-11-20 |
Lilly Co Eli |
مركبات تترا هيدرو فوروكسازين واستخداماتها كمثبطات bace1 انتقائية
|
|
JP2019532992A
(ja)
*
|
2016-11-04 |
2019-11-14 |
ヤンセン ファーマシューティカ エヌ．ベー． |
４，４ａ，５，７−テトラヒドロ−３ｈ−フロ［３，４−ｂ］ピリジニル化合物
|
|
CA3047288A1
(en)
|
2016-12-15 |
2018-06-21 |
Amgen Inc. |
Thiazine derivatives as beta-secretase inhibitors and methods of use
|
|
MX394391B
(es)
|
2016-12-15 |
2025-03-24 |
Amgen Inc |
Derivados de tiazina y oxazina biciclicos como inhibidores de beta-secretasa y metodos de uso.
|
|
EP3555085B1
(en)
|
2016-12-15 |
2020-12-02 |
Amgen Inc. |
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
|
|
CA3047290A1
(en)
|
2016-12-15 |
2018-06-21 |
Amgen Inc. |
1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
|
|
AU2017376441B2
(en)
|
2016-12-15 |
2021-10-14 |
Amgen Inc. |
Oxazine derivatives as beta-secretase inhibitors and methods of use
|
|
JP2020509074A
(ja)
*
|
2017-03-07 |
2020-03-26 |
ヤンセン ファーマシューティカ エヌ．ベー． |
βセクレターゼ阻害剤
|
|
WO2018162444A1
(en)
*
|
2017-03-07 |
2018-09-13 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
US20190389882A1
(en)
*
|
2017-03-07 |
2019-12-26 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
WO2018162445A1
(en)
*
|
2017-03-07 |
2018-09-13 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
JP2020509068A
(ja)
*
|
2017-03-07 |
2020-03-26 |
ヤンセン ファーマシューティカ エヌ．ベー． |
βセクレターゼ阻害剤
|
|
EA201992076A1
(ru)
*
|
2017-09-07 |
2020-03-19 |
Янссен Фармацевтика Нв |
Ингибиторы бета-секретазы
|
|
CN110590517A
(zh)
*
|
2019-09-24 |
2019-12-20 |
武汉嘉诺康医药技术有限公司 |
一种3，4-二羟基-2′-氯苯乙酮的制备方法
|